RK
Richard King
Chief Operating Officer

Richard King insider trades: Adamas Pharmaceuticals (ADMS) stock buys and sales

Chief Operating Officer, Adamas Pharmaceuticals Last trade Jun 21, 2018 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2005
5
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Richard reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 21, 2018ADMS↓ Sell$64K
Jun 9, 2011ACRX↑ Buy$16K
Mar 10, 2006KOSP↓ Sell$250K
Feb 16, 2006KOSP↓ Sell$250K
Jan 3, 2006KOSP↓ Sell$252K
Dec 1, 2005KOSP↓ Sell$199K
Nov 1, 2005KOSP↓ Sell$178K
Oct 3, 2005KOSP↓ Sell$200K
Sep 1, 2005KOSP↓ Sell$203K
Aug 1, 2005KOSP↓ Sell$214K
Jul 1, 2005KOSP↓ Sell$196K
May 6, 2005KOSP↓ Sell$537K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Richard King's insider trades

Richard King is Chief Operating Officer at Adamas Pharmaceuticals (ADMS). Since May 6, 2005, Richard has reported 1 open-market purchase worth $16K and 11 sales worth $2.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (12 filings), option exercises (10 filings), other transactions (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADMS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.